Joel Isaacson & Co., LLC Cerus Corp Transaction History
Joel Isaacson & Co., LLC
- $2.39 Billion
- Q2 2025
A detailed history of Joel Isaacson & Co., LLC transactions in Cerus Corp stock. As of the latest transaction made, Joel Isaacson & Co., LLC holds 40,000 shares of CERS stock, worth $65,199. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40,000
Previous 40,000
-0.0%
Holding current value
$65,199
Previous $55,000
1.82%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CERS
# of Institutions
165Shares Held
139MCall Options Held
100KPut Options Held
16K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl19.2MShares$31.3 Million0.22% of portfolio
-
Black Rock Inc. New York, NY13.9MShares$22.6 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY12.9MShares$21 Million0.18% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.7MShares$17.5 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT8.53MShares$13.9 Million0.07% of portfolio
About CERUS CORP
- Ticker CERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 177,090,000
- Market Cap $289M
- Description
- Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...